The Migraine Drugs Market is poised for substantial expansion, with market size projected to escalate from USD 5.47 billion in 2024 to approximately USD 8.12 billion by 2035. This transformation is underpinned by a compound annual growth rate (CAGR) of 3.65%. The surge in market size indicates a growing recognition of the debilitating impact of migraines, leading to an increase in treatment...
Bangla